Use your smartphone to detect atrial fibrillation
Precordior’s CardioSignal smartphone application helps people to improve their lives and to access critical health information.
Atrial fibrillation (AFib) is a heart rhythm disorder of the atria, which affects approximately 2% of the global population and causes up to 40% of all strokes worldwide. With CardioSignal application anyone can detect Afib in time and seek for medical assistance in time.
Technology in your pocket
There are over 2 billion smartphone users. With our technology, most of the people can access to critical information of their own health using a smartphone. We will provide affordable solutions for the masses, available to virtually anyone.
CardioSignal application uses phone sensors to detect atrial fibrillation with 96% accuracy. Our patented method is the best in the market compared to competing solutions and we can do it utilizing built-in smartphone features. No extra accessories needed.
Precordior as a Company
Precordior was founded by a group of medical, technology and business experts who decided to go beyond just making devices, lifestyle or fitness applications. In everything we do at Precordior, we aim to make a difference. Saving someone’s life. Giving someone a better life. Helping someone live a longer and healthier life.
All respect to the technology buzz, fancy games
Every human being is equally valuable, regardless of their age, gender, financial status, or where they live. We believe that everyone has the right to be alerted of dangerous health conditions, to seek medical assistance in time. We believe that everyone is entitled to a long and healthy life.
Our goal is to give every person in the world access to critical information on their own health. We will develop simple solutions for smartphones as well as miniature monitoring devices. We will provide affordable solutions for the masses, available to virtually anyone around the world.
Our vision is to provide Precordior technology to everyone also via our partner services. We can extend our technology to detect other heart related deceases such as heart failure (HF), coronary artery disease (CAD) and heart failure with preserved ejection fraction (HFpEF).